Literature DB >> 24214489

Family history and clefting as major criteria for CHARGE syndrome.

Susan Starling Hughes1, Holly I Welsh, Nicole P Safina, Khemissa Bejaoui, Holly H Ardinger.   

Abstract

CHARGE syndrome is an autosomal dominant malformation syndrome associated with mutations in CHD7. The condition is typically sporadic with few familial cases reported. The diagnosis of CHARGE syndrome is based on a combination of major and minor criteria comprised of structural and functional abnormalities, most of which are part of the original CHARGE acronym, although additional anomalies have been added. To date, family history has not been considered in the diagnostic criteria. Here we report a family with a previously unreported missense mutation in exon 31 of CHD7, in which family history played a role in the diagnosis of CHARGE syndrome. Given the tremendous phenotypic variability and the dominant nature of CHARGE syndrome, we propose that family history be included as a major diagnostic criterion. A positive family history would include any individual with an apparently isolated unilateral major CHARGE anomaly or someone with a few of the minor features. Our cases support this proposal; had family history not been considered in this case, CHD7 testing might not have been pursued, leading to incomplete medical follow-up and erroneous genetic counseling. Additionally, with the increased incidence of orofacial clefting in this family, as well as in the literature, we suggest that cleft lip and/or palate be added to the major diagnostic criteria for CHARGE syndrome.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CHARGE; CHARGE association; CHARGE syndrome; CHD7; diagnostic criteria; familial CHARGE syndrome; family history; orofacial clefting

Mesh:

Substances:

Year:  2013        PMID: 24214489     DOI: 10.1002/ajmg.a.36192

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria.

Authors:  Caitlin L Hale; Adrienne N Niederriter; Glenn E Green; Donna M Martin
Journal:  Am J Med Genet A       Date:  2015-11-21       Impact factor: 2.802

2.  Modeling human craniofacial disorders in Xenopus.

Authors:  Aditi Dubey; Jean-Pierre Saint-Jeannet
Journal:  Curr Pathobiol Rep       Date:  2017-01-24

3.  Variant analysis of the chromodomain helicase DNA-binding protein 7 in pediatric disorders of sex development.

Authors:  Beibei Zhang; Yanning Song; Wei Li; Chunxiu Gong
Journal:  Pediatr Investig       Date:  2019-03-22

4.  The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development.

Authors:  Ethan D Sperry; Elizabeth A Hurd; Mark A Durham; Elyse N Reamer; Adam B Stein; Donna M Martin
Journal:  Dev Dyn       Date:  2014-07-10       Impact factor: 3.780

5.  Genetic analysis of CHARGE syndrome identifies overlapping molecular biology.

Authors:  Amanda Moccia; Anshika Srivastava; Jennifer M Skidmore; John A Bernat; Marsha Wheeler; Jessica X Chong; Deborah Nickerson; Michael Bamshad; Margaret A Hefner; Donna M Martin; Stephanie L Bielas
Journal:  Genet Med       Date:  2018-01-04       Impact factor: 8.822

6.  A case series of CHARGE syndrome: identification of key features for a neonatal diagnosis.

Authors:  Maria Francesca Bedeschi; Beatrice Letizia Crippa; Lorenzo Colombo; Martina Buscemi; Cesare Rossi; Roberta Villa; Silvana Gangi; Odoardo Picciolini; Claudia Cinnante; Viola Giulia Carlina Fergnani; Paola Francesca Ajmone; Elisa Scola; Fabio Triulzi; Fabio Mosca
Journal:  Ital J Pediatr       Date:  2020-04-23       Impact factor: 2.638

7.  Rapid Discovery of De Novo Deleterious Mutations in Cattle Enhances the Value of Livestock as Model Species.

Authors:  E Bourneuf; P Otz; H Pausch; V Jagannathan; P Michot; C Grohs; G Piton; S Ammermüller; M-C Deloche; S Fritz; H Leclerc; C Péchoux; A Boukadiri; C Hozé; R Saintilan; F Créchet; M Mosca; D Segelke; F Guillaume; S Bouet; A Baur; A Vasilescu; L Genestout; A Thomas; A Allais-Bonnet; D Rocha; M-A Colle; C Klopp; D Esquerré; C Wurmser; K Flisikowski; H Schwarzenbacher; J Burgstaller; M Brügmann; E Dietschi; N Rudolph; M Freick; S Barbey; G Fayolle; C Danchin-Burge; L Schibler; B Bed'Hom; B J Hayes; H D Daetwyler; R Fries; D Boichard; D Pin; C Drögemüller; A Capitan
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.